» Articles » PMID: 28991922

Clonal Dominance and Transplantation Dynamics in Hematopoietic Stem Cell Compartments

Overview
Specialty Biology
Date 2017 Oct 10
PMID 28991922
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Hematopoietic stem cells in mammals are known to reside mostly in the bone marrow, but also transitively passage in small numbers in the blood. Experimental findings have suggested that they exist in a dynamic equilibrium, continuously migrating between these two compartments. Here we construct an individual-based mathematical model of this process, which is parametrised using existing empirical findings from mice. This approach allows us to quantify the amount of migration between the bone marrow niches and the peripheral blood. We use this model to investigate clonal hematopoiesis, which is a significant risk factor for hematologic cancers. We also analyse the engraftment of donor stem cells into non-conditioned and conditioned hosts, quantifying the impact of different treatment scenarios. The simplicity of the model permits a thorough mathematical analysis, providing deeper insights into the dynamics of both the model and of the real-world system. We predict the time taken for mutant clones to expand within a host, as well as chimerism levels that can be expected following transplantation therapy, and the probability that a preconditioned host is reconstituted by donor cells.

Citing Articles

Stem cell graft dose and composition could impact on the expansion of donor-derived clones after allogeneic hematopoietic stem cell transplantation - a virtual clinical trial.

Stiehl T Front Immunol. 2024; 15:1321336.

PMID: 39737169 PMC: 11682905. DOI: 10.3389/fimmu.2024.1321336.


Modelling post-chemotherapy stem cell dynamics in the bone marrow niche of AML patients.

Zhu C, Stiehl T Sci Rep. 2024; 14(1):25060.

PMID: 39443599 PMC: 11500015. DOI: 10.1038/s41598-024-75429-7.


Mathematical modelling of stem and progenitor cell dynamics during ruxolitinib treatment of patients with myeloproliferative neoplasms.

Boklund T, Snyder J, Gudmand-Hoeyer J, Larsen M, Knudsen T, Eickhardt-Dalboge C Front Immunol. 2024; 15:1384509.

PMID: 38846951 PMC: 11154009. DOI: 10.3389/fimmu.2024.1384509.


Computational modeling reveals key factors driving treatment-free remission in chronic myeloid leukemia patients.

Lai X, Jiao X, Zhang H, Lei J NPJ Syst Biol Appl. 2024; 10(1):45.

PMID: 38678088 PMC: 11055880. DOI: 10.1038/s41540-024-00370-4.


Somatic epimutations enable single-cell lineage tracing in native hematopoiesis across the murine and human lifespan.

Scherer M, Singh I, Braun M, Szu-Tu C, Kardorff M, Ruhle J bioRxiv. 2024; .

PMID: 38617287 PMC: 11014487. DOI: 10.1101/2024.04.01.587514.


References
1.
Quesenberry P, Stewart F, Becker P, Dhondt L, Frimberger A, Lambert J . Stem cell engraftment strategies. Ann N Y Acad Sci. 2001; 938:54-61; discussion 61-2. DOI: 10.1111/j.1749-6632.2001.tb03574.x. View

2.
Wright D, Wagers A, Gulati A, Johnson F, Weissman I . Physiological migration of hematopoietic stem and progenitor cells. Science. 2001; 294(5548):1933-6. DOI: 10.1126/science.1064081. View

3.
Roeder I, Loeffler M . A novel dynamic model of hematopoietic stem cell organization based on the concept of within-tissue plasticity. Exp Hematol. 2002; 30(8):853-61. DOI: 10.1016/s0301-472x(02)00832-9. View

4.
Abkowitz J, Catlin S, McCallie M, Guttorp P . Evidence that the number of hematopoietic stem cells per animal is conserved in mammals. Blood. 2002; 100(7):2665-7. DOI: 10.1182/blood-2002-03-0822. View

5.
Kondo M, Wagers A, Manz M, Prohaska S, Scherer D, Beilhack G . Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol. 2003; 21:759-806. DOI: 10.1146/annurev.immunol.21.120601.141007. View